Particle Therapy Market Worth $1,004 Million by 2027 – Exclusive Report by MarketsandMarkets™

Prominent players in the particle therapy market include IBA Worldwide (EU), Varian Medical Systems, Inc. (US), Hitachi, Ltd. (Japan), Mevion Medical Systems (US), and Sumitomo Heavy Industries, Ltd. (Japan).
In January 2019, Varian Medical Systems, Inc. (US) partnership with Oncora Medical (US). This investment partnership was aimed at accelerating the development of software tools to enable precision medicine in radiation oncology.

According to the new market research report Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027″, published by MarketsandMarkets™, the global market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027.

Browse in-depth TOC on “Particle Therapy Market”
168 – Tables
46 – Figures
209 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137

In this report, the market is segmented on the basis of type, products and services, cancer type, systems, and region.

“Pediatric cancer defined for the largest share in the particle therapy market by cancer type”

Based on cancer type, the market is segmented into prostate cancer. pediatric cancer, lung cancer, breast cancer, head & neck cancer, and other cancers. The pediatric cancer segment holds the largest share of 24.8% of the market in 2021 with CAGR of 10.4% during the forecast period. The growing incidence of pediatric cancer alongside the high success rates is the major factors driving the growth of this market segment.

“Products such as cyclotron accounted for the largest share in the particle therapy market by product type”

Based on products & services, the market is segmented into products and services. In 2021, products are estimated to account for the largest share of 78.6% of the particle therapy market. The increasing incidence of cancer cases is the major factor responsible for the growth of this segment.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=12809137

“Based on system, multi-room systems holds the largest share in the particle therapy”

Based on the system, the particle therapy market is segmented into single-room and multi-room particle therapy systems. The multi-room systems segment is expected to account for the largest share (67.8%) of the market. The large share of this segment can be attributed to the growing availability of these systems and their lower shielding requirements as compared to single-room systems.

Key Market Players:

Prominent players in the particle therapy market include IBA Worldwide (EU), Mevion Medical Systems (US), Varian Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Hitachi, Ltd. (Japan), Toshiba Medical Systems Corporation (Japan), and Provision Healthcare, LLC (US). These players have implemented various development strategies such as product launches, acquisition, and expansion to other geography.

Media Contact
Company Name: MarketsandMarkets Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/particle-therapy-market-12809137.html

Are you a market researcher?

Explore our research partnership options.

Partnerships

Find out what people like and dislike about your competitors, and compare it with your brand performance.

Competitor Analyzer

Generated by Feedzy
%d bloggers like this: